ACIU

AC Immune News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
AC Immune SA ACIU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 1.71% 7.72 11:56:01
Open Price Low Price High Price Close Price Prev Close
7.73 7.60 7.8501 7.59
more quote information »

Recent News

Date Time Source Heading
3/01/20216:28IHNWFeaturedEmerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more ....
3/01/20213:56IHNWFeaturedManganese X Notes and Applauds President Biden's Executive Order to Secure America's Critical Supply Chains for Manganese and Electric Vehicle Batteries
3/01/20219:00IHNWFeaturedAmerican Green, Inc.™ (OTC:ERBB) Issues Update on U.S. Cannabis Cultivation Expansion
2/26/202106:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/12/202117:23EDGARStatement of Ownership (sc 13g)
2/12/202111:00EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202108:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/22/202116:28EDGARStatement of Ownership (sc 13g)
1/14/202116:48EDGARAmended Statement of Ownership (sc 13g/a)
11/23/202016:31EDGARAmended Report of Foreign Issuer Pursuant to Rule 13a-16 or..
11/23/202006:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/18/202008:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/23/202017:24EDGARSecurities Registration (foreign Private Issuer) (f-3)
10/21/202006:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/23/202013:30DJNAC Immune Down 43%; Semorinemab Didn't Meet Endpoint in..
9/23/202009:23DJNAC Immune Down; Semorinemab Didn't Meet Efficacy Endpoint in..
9/23/202007:59DJNAC Immune: Semorinemab Didn't Meet Co-Primary Efficacy..
9/23/202007:56EDGARReport of Foreign Issuer (6-k)
9/08/202017:18EDGARReport of Foreign Issuer (6-k)
9/08/202017:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/05/202007:30EDGARReport of Foreign Issuer (6-k)
7/16/202008:30EDGARReport of Foreign Issuer (6-k)
6/26/202016:52EDGARReport of Foreign Issuer (6-k)
5/22/202008:40EDGARReport of Foreign Issuer (6-k)
5/04/202008:32EDGARReport of Foreign Issuer (6-k)
4/02/202007:12EDGARReport of Foreign Issuer (6-k)
3/30/202009:09EDGARReport of Foreign Issuer (6-k)
3/30/202009:06EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/23/202008:15EDGARReport of Foreign Issuer (6-k)
See more news about this stock »


Your Recent History
NASDAQ
ACIU
AC Immune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.